Prescription medication · Acetylcholinesterase Inhibitor

donepezil

Also sold as Aricept. Donepezil treats dementia in people with Alzheimer's disease.

Data updated 2026-05-15

35,138
FDA reportsModerately reported
2
InteractionsFew interactions
99% less
Generic vs brandHuge savings
$16.20
Brand price (NADAC)

What the data shows

donepezil (Aricept) is a prescription Acetylcholinesterase Inhibitor, reported at a middle-of-the-pack volume (35,138 FDA reports), whose generic costs a fraction of the brand (about 99% less).

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

donepezil (Aricept) is a prescription Acetylcholinesterase Inhibitor. Donepezil treats dementia in people with Alzheimer's disease.

Donepezil is a medicine used to treat dementia caused by Alzheimer's disease. It can help improve memory and thinking.

Drug Pricing (NADAC)

Brand Price

$16.20/unit

Generic Price

$0.05/unit

Generic Savings

99%

Generic Available

Yes (20 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: DONEPEZIL HCL 10 MG TABLET

Same CMS presentation as the headline generic unit price above (3 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +12.1% vs prior release.

4.2¢4.4¢4.6¢4.8¢ 2024-022024-042024-12 4.89¢
Effective NADAC / unit vs prior NDCs
February 21, 2024 $0.0492/EA - 1
April 17, 2024 $0.0436/EA -11.4% 2
December 18, 2024 $0.0489/EA +12.1% 31
View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Donepezil treats dementia in people with Alzheimer's disease.

Common side effects

Nausea, Diarrhea, Trouble sleeping

Key warnings

This medicine can slow your heart rate or cause fainting.

The sections below are summarized in plain English from donepezil's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Donepezil works by increasing a chemical in the brain called acetylcholine. This chemical helps nerve cells communicate better. By increasing acetylcholine, donepezil can improve mental function in people with Alzheimer's.

Side Effects (from patient reports)

Based on 35,138 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for donepezil, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for donepezil each year to the FDA Adverse Event Reporting System (FAERS).

01,0002,0003,000 200320062009201220152018202120242025 2,412

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where donepezil sits

donepezil has more FDA adverse-event reports than 67% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is donepezil; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 35,138 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.

Total Reports

35,138

Reports Mentioning Death

5,622

16.0% of reports — not proof of cause

Hospitalization Reports

14,136

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 17,411 (54%)
Male 14,683 (46%)

Age Distribution

0–17 191
18–44 325
45–64 2,491
65–74 5,309
75+ 16,404

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FALL 2,965
2 DEATH 2,020
3 CONFUSIONAL STATE 1,893
4 DIARRHOEA 1,738
5 DIZZINESS 1,732
6 FATIGUE 1,686
7 NAUSEA 1,599
9 HALLUCINATION 1,481
10 ASTHENIA 1,476
11 SOMNOLENCE 1,330
12 VOMITING 1,276
13 DRUG INTERACTION 1,205
14 DECREASED APPETITE 1,170
15 DYSPNOEA 1,069
16 DEMENTIA 1,062

Reactions in Death Reports

DEATH 2,015
FALL 598
SEPSIS 387
DYSPNOEA 363
ASTHENIA 361
CARDIO-RESPIRATORY ARREST 345
FATIGUE 340
DIZZINESS 333
DIARRHOEA 315
DECREASED APPETITE 310

Reactions in Hospitalization Reports

FALL 1,831
CONFUSIONAL STATE 842
BRADYCARDIA 753
URINARY TRACT INFECTION 728
PNEUMONIA 683
DIARRHOEA 682
SYNCOPE 659
ASTHENIA 647
NAUSEA 633
VOMITING 611

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

This medicine can slow your heart rate or cause fainting. Tell your doctor if you have heart problems. Donepezil can also cause nausea, vomiting, and stomach bleeding. Watch for these side effects, especially when you start taking it or when your dose is increased.

Known Drug Interactions

7.2 Use with Cholinomimetics and Other Cholinesterase Inhibitors A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists such as bethanechol.

Mechanism: Both drugs work in a similar way to increase a specific chemical in the body. Taking them together can make this effect much stronger than intended.

( 7.1 ) Donepezil: Increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with donepezil. Donepezil The AUC 0-inf and C max of ramelteon increased by approximately 100% and 87%, respectively upon coadministration of donepezil with ramelteon. Patients should be closely monitored when ramelteon is coadministered with donepezil [see Clinical Pharmacology (12.5) ] .

Mechanism: Donepezil makes it harder for your body to get rid of ramelteon, leading to higher levels of the drug in your blood.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

What should I do if I feel sick after taking donepezil?
Tell your doctor if you have nausea, vomiting, or diarrhea. These side effects are common, but your doctor may be able to help you manage them.
Can donepezil cure Alzheimer's disease?
No, donepezil does not cure Alzheimer's disease. It can help improve symptoms, but it does not stop the disease from getting worse.
How long will I need to take donepezil?
You will likely need to take donepezil for as long as your doctor thinks it is helping you. Talk to your doctor before stopping this medicine.
Will donepezil interact with other medicines I am taking?
Donepezil can interact with some other medicines. Tell your doctor about all the medicines you take, including over-the-counter drugs and supplements.
Can I drive while taking donepezil?
Donepezil can cause dizziness or sleepiness. Be careful driving or doing anything that requires you to be alert until you know how this medicine affects you.
What dose of Donepezil should I take?
For mild to moderate Alzheimer's, start with 5mg once daily. The maximum dose is 10mg daily. For moderate to severe Alzheimer's, the maximum dose is 23mg daily.
When should I increase my dose?
Do not increase to 10mg until you have been on 5mg daily for 4-6 weeks. Do not increase to 23mg until you have been on 10mg daily for at least 3 months.
What are the inactive ingredients in the 23mg tablet?
They include colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, and sodium starch glycolate.
What does the tablet look like?
The 23 mg tablets are reddish brown, round, and film-coated, with 'G52' on one side and 'LU' on the other.
What if I weigh less than 55kg?
Patients weighing less than 55 kg may experience more nausea, vomiting, and weight loss.
What are the common side effects of donepezil?
The registry lists Nausea, Diarrhea, Trouble sleeping, Vomiting, Muscle cramps among the most-reported FAERS reaction terms for donepezil. The compiled record contains 35,138 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does donepezil interact with other medications?
The registry has 2 documented interaction rows for donepezil. Notable source-record pairings include bethanechol, ramelteon. These rows are not a complete medication review.
What drug class is donepezil?
donepezil belongs to the Acetylcholinesterase Inhibitor drug class. It requires a prescription (Rx). Donepezil treats dementia in people with Alzheimer's disease.
Is there a generic version of donepezil?
Yes, generic donepezil is available from 20 manufacturers. The generic costs $0.05 per unit compared to $16.20 for the brand version, saving approximately 99%. Pricing is based on NADAC (National Average Drug Acquisition Cost) data from CMS.
What pregnancy or breastfeeding source fields are listed for donepezil?
The FDA label for donepezil contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near donepezil - same-class peers and common alternatives.

Compare donepezil vs acamprosate side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for donepezil: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on donepezil

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for donepezil

The FDA label for donepezil (sold under brand names such as Aricept) classifies it as a prescription-only medication in the Acetylcholinesterase Inhibitor class. Donepezil treats dementia in people with Alzheimer's disease. Official labeling lists 7 commonly reported side effects, including Nausea, Diarrhea, Trouble sleeping.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 35,138 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.05 versus $16.20 for the brand - a 99% generic savings.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: November 29, 2024

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page